Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

Erin A. Bohula, Benjamin M. Scirica, Silvio E. Inzucchi, Darren K. McGuire, Anthony C. Keech, Steven R. Smith, Estella Kanevsky, Sabina A. Murphy, Lawrence A. Leiter, Jamie P. Dwyer, Ramon Corbalan, Christian Hamm, Lee Kaplan, Jose Carlos Nicolau, Ton Oude Ophuis, Kausik K. Ray, Mikhail Ruda, Jindrich Spinar, Tushar Patel, Wenfeng MiaoCarlos Perdomo, Bruce Francis, Shobha Dhadda, Marc P. Bonaca, Christian T. Ruff, Marc S. Sabatine, Stephen D. Wiviott, CAMELLIA-TIMI 61 Steering Committee Investigators

Research output: Contribution to journalArticle

27 Citations (Scopus)

Fingerprint Dive into the research topics of 'Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences